ILSEUNG Co., Ltd. (KOSDAQ:333430)
3,420.00
+125.00 (3.79%)
At close: Oct 16, 2026
ILSEUNG Revenue
ILSEUNG had revenue of 16.23B KRW in the quarter ending June 30, 2026, with 40.05% growth. This brings the company's revenue in the last twelve months to 57.36B, up 10.20% year-over-year. In the year 2025, ILSEUNG had annual revenue of 50.67B, down -2.16%. That makes ILSEUNG the 29,036th largest company in the world by revenue and 1,784th in South Korea.
Revenue (ttm)
57.36B
Revenue Growth
+10.20%
P/S Ratio
1.76
Revenue / Employee
3.82B
Employees
15
Market Cap
104.93B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 50.67B | -1.12B | -2.16% |
| Dec 31, 2024 | 51.79B | -1.18B | -2.22% |
| Dec 31, 2023 | 52.97B | -12.07B | -18.55% |
| Dec 31, 2022 | 65.04B | 23.14B | 55.24% |
| Dec 31, 2021 | 41.90B | 4.79B | 12.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Sangsangin | 452.07B |
| Daewon Media | 423.84B |
| Hyundai Everdigm | 303.93B |
| Woorison F&G | 294.85B |
| TOPTEC | 173.29B |
| Daejung Chemicals & Metals | 119.27B |
| High Tech Pharm | 69.41B |
| CG MedTech | 51.20B |